Cover Image
Market Research Report

Genomics in Cancer Care Market - Growth, Trends And Forecast (2020 - 2025)

Published by Mordor Intelligence LLP Product code 927883
Published Content info 117 Pages
Delivery time: 2-3 business days
Price
Back to Top
Genomics in Cancer Care Market - Growth, Trends And Forecast (2020 - 2025)
Published: March 1, 2020 Content info: 117 Pages
Description

The Genomics in Cancer Care Market is expected to register a CAGR of 17.5% during the forecast period. High prevalence of cancer and developing technology related to cancer care is expected to be the major factors to propel the market growth. Cancer is considered as the leading cause of death. According to the World Health Organization, in 2018, almost 9.6 million death were caused due to cancer worldwide. Moreover, every one out of six death is because of cancer. However, high cost of procedures involved may obstruct the market growth.

Key Market Trends

Gene Sequencing Segment is Expected to Hold a Major Market Share in the Genomics in Cancer Care Market

  • Emerging technology related to gene sequencing is expected to fuel the market growth. Next generation sequencing is a novel method having wide application into oncology. The sequencing of DNA and RNA helps in detecting and analysing the modifiers, mutation analysis and pharmacogenetics of biopsy.
  • Furthermore, it's advantages over other techniques in known to boost the particular segment. According to the study published in 2017 by the International Journal of Molecular Sciences, for PCR, the genome had to be sequenced per tube which consumes a lot of time and money whereas in case of next generation sequencing the whole genome can be sequenced in few days with less than 1000 USD per genome.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the global genomics in cancer care market due to higher incidence rates of cancer disease and the initiatives taken by government and other organizations related to genomics cancer. According to the National Cancer Institutes, in 2018 the incidence rate for cancer in the United States was around 1,735,350. Furthermore, National Cancer Institutes has established a program "Cancer Genome Atlas Programme". It is the database wherein around 2.5 petabytes of data is stored related to genomics. This further is being used for cancer diagnosis and treatment development. Hence, this factor is expected to boost the genomics in cancer care market growth.

Competitive Landscape

Companies are adopting growth strategies such as collaborations, mergers and acquisition. For instance, Roche Diagnostics partnered with Illumina, Inc., for the development of assays and next generation sequencing with respect to cancer. Some of the companies which are currently dominating the market are Illumina Inc., ThermoFisher Scientific Inc., Agilent Technologies, Cancer Genetics Inc., GE Healthcare, Intrexon Bioinformatics Germany GmbH, Quest Diagnostics, Roche Diagnostics, Merck KGaA and Pacific Biosciences, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support
Table of Contents
Product Code: 68337

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cancer
    • 4.2.2 Initiatives taken by Companies in Product Development
  • 4.3 Market Restraints
    • 4.3.1 High Cost
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Instruments
    • 5.1.2 Consumables
    • 5.1.3 Services
  • 5.2 By Technology
    • 5.2.1 PCR
    • 5.2.2 MicroArrays
    • 5.2.3 Genome Sequencing
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Cancer Genetics Inc.
    • 6.1.3 GE Healthcare
    • 6.1.4 Merck KGaA
    • 6.1.5 Illumina Inc.
    • 6.1.6 Intrexon Bioinformatics Germany GmbH
    • 6.1.7 Pacific Biosciences, Inc.
    • 6.1.8 Quest Diagnostics
    • 6.1.9 Roche Diagnostics
    • 6.1.10 ThermoFisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top